Astrazeneca Pharma India Ltd.
•₹ 7,415.5-1.22%
2026-08-21
ABOUT
KEY POINTS
Revenue Breakup Mar 2026 • Injectables: 46.6% • Tablets: 46.0% • Clinical Trial Services: 5.1% • Inhalation: 1.6% • Powder: 0.6% • Others: 0.1%
PROS
- Company is almost debt free
- Company has a healthy return on capital (ROCE) of 28.8%
- Company has a good return on equity (ROE) track record: 3 Years ROE 21.2%
- Company has delivered good sales growth of 22.8% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 48.0%
CONS
- Operating cash flow has been negative in recent years
- Recent results are weak - TTM profit is down 15.5% versus prior year
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.17x)
- Stock is trading at 22.4x its book value
- Operating margins have contracted to 11.5% from 19.0%
- Recurring exceptional / one-off items are inflating headline profit
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1901.00 | 37.71 | 456113.58 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8587.00 | 77.93 | 227957.87 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 4994.90 | 87.11 | 189989.94 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1437.65 | 34.46 | 116141.01 | 0.90 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1108.80 | 24.51 | 110603.22 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2203.10 | 18.22 | 100733.42 | 0.82 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | DRREDDY | 1181.35 | 30.60 | 98604.43 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 8. | MANKIND | 2385.00 | 48.22 | 98499.54 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 9. | LAURUSLABS | 1823.00 | 90.09 | 98498.92 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1606.40 | 24.90 | 92428.71 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 412.10 | 135.59 | 67159.70 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | ASTRAZEN | 7504.30 | 0.00 | 18760.75 | 0.48 | 37.93 | -32.06 | 682.79 | 29.73 | 31.24 | 7.17 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 295 | 311 | 306 | 383 | 388 | 408 | 440 | 480 | 526 | 559 | 612 | 579 | 683 | |
| 228 | 258 | 291 | 334 | 349 | 355 | 363 | 394 | 445 | 484 | 567 | 518 | 641 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 8 | 8 | 10 | 9 | 8 | 8 | 8 | 16 | 11 | 6 | 5 | 6 | 9 |
| Interest | 0 | 0 | 1 | -0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 9 | 9 | 18 | 17 | 3 | 4 | 6 | 5 |
| 71 | 73 | 20 | 54 | -15 | 51 | 42 | 78 | 75 | 73 | 47 | 58 | 51 | |
| Tax % | 24.57% | 28.63% | 22.55% | 27.37% | 22.23% | 24.69% | 26.58% | 25.77% | 25.26% | 25.54% | 29.97% | 22.81% | 25.26% |
| Net Profit | 54 | 52 | 16 | 39 | -12 | 38 | 31 | 58 | 56 | 54 | 33 | 45 | 38 |
| 22 | 21 | 6 | 16 | -5 | 15 | 12 | 23 | 22 | 22 | 13 | 18 | 2 | |
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 295
- 228
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 0
- Depreciation
- 4
- 71
- Tax %
- 24.57%
- Net Profit
- 54
- 22
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 311
- 258
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 0
- Depreciation
- 4
- 73
- Tax %
- 28.63%
- Net Profit
- 52
- 21
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 306
- 291
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 1
- Depreciation
- 4
- 20
- Tax %
- 22.55%
- Net Profit
- 16
- 6
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 383
- 334
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- -0
- Depreciation
- 4
- 54
- Tax %
- 27.37%
- Net Profit
- 39
- 16
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 388
- 349
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 0
- Depreciation
- 4
- -15
- Tax %
- 22.23%
- Net Profit
- -12
- -5
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 408
- 355
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 0
- Depreciation
- 9
- 51
- Tax %
- 24.69%
- Net Profit
- 38
- 15
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 440
- 363
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 0
- Depreciation
- 9
- 42
- Tax %
- 26.58%
- Net Profit
- 31
- 12
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 480
- 394
- Operating Profit
- —
- OPM %
- —
- Other Income
- 16
- Interest
- 1
- Depreciation
- 18
- 78
- Tax %
- 25.77%
- Net Profit
- 58
- 23
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 526
- 445
- Operating Profit
- —
- OPM %
- —
- Other Income
- 11
- Interest
- 1
- Depreciation
- 17
- 75
- Tax %
- 25.26%
- Net Profit
- 56
- 22
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 559
- 484
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 1
- Depreciation
- 3
- 73
- Tax %
- 25.54%
- Net Profit
- 54
- 22
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 612
- 567
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 1
- Depreciation
- 4
- 47
- Tax %
- 29.97%
- Net Profit
- 33
- 13
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 579
- 518
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 2
- Depreciation
- 6
- 58
- Tax %
- 22.81%
- Net Profit
- 45
- 18
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 683
- 641
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 2
- Depreciation
- 5
- 51
- Tax %
- 25.26%
- Net Profit
- 38
- 2
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 5
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 544 | 571 | 728 | 832 | 814 | 806 | 1,003 | 1,296 | 1,716 | 2,276 | 2,432 | |
| 507 | 525 | 657 | 711 | 678 | 719 | 838 | 1,111 | 1,462 | 2,014 | 2,209 | |
| Operating Profit | 51 | 59 | 88 | 134 | 148 | 101 | 191 | 219 | 295 | 291 | — |
| OPM % | 9 | 10 | 12 | 16 | 18 | 13 | 19 | 17 | 17 | 13 | — |
| Other Income | 14 | 12 | 16 | 13 | 13 | 15 | 26 | 35 | 41 | 28 | 26 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 |
| Depreciation | 16 | 15 | 15 | 19 | 20 | 17 | 16 | 15 | 40 | 29 | 17 |
| 36 | 44 | 73 | 114 | 127 | 83 | 134 | 220 | 156 | 252 | 228 | |
| Tax % | 44 | 41 | 25 | 37 | 27 | 26 | 26 | 26 | 26 | 26 | 26 |
| Net Profit | 20 | 26 | 54 | 72 | 93 | 62 | 99 | 162 | 116 | 188 | 170 |
| EPS | 8 | 10 | 22 | 29 | 37 | 25 | 40 | 65 | 46 | 75 | — |
| Dividend Payout % | 0 | 0 | 0 | 3 | 5 | 41 | 40 | 37 | 69 | 48 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 8 | 10 | 22 | 29 | 37 | 25 | 40 | 65 | 46 | 75 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 8 | 10 | 22 | 29 | 37 | 25 | 40 | 65 | 46 | 75 | — |
Mar 2017
- 544
- 507
- Operating Profit
- 51
- OPM %
- 9
- Other Income
- 14
- Interest
- 0
- Depreciation
- 16
- 36
- Tax %
- 44
- Net Profit
- 20
- EPS
- 8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
Mar 2018
- 571
- 525
- Operating Profit
- 59
- OPM %
- 10
- Other Income
- 12
- Interest
- 0
- Depreciation
- 15
- 44
- Tax %
- 41
- Net Profit
- 26
- EPS
- 10
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2019
- 728
- 657
- Operating Profit
- 88
- OPM %
- 12
- Other Income
- 16
- Interest
- 0
- Depreciation
- 15
- 73
- Tax %
- 25
- Net Profit
- 54
- EPS
- 22
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 22
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 22
Mar 2020
- 832
- 711
- Operating Profit
- 134
- OPM %
- 16
- Other Income
- 13
- Interest
- 1
- Depreciation
- 19
- 114
- Tax %
- 37
- Net Profit
- 72
- EPS
- 29
- Dividend Payout %
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 29
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 29
Mar 2021
- 814
- 678
- Operating Profit
- 148
- OPM %
- 18
- Other Income
- 13
- Interest
- 1
- Depreciation
- 20
- 127
- Tax %
- 27
- Net Profit
- 93
- EPS
- 37
- Dividend Payout %
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 37
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 37
Mar 2022
- 806
- 719
- Operating Profit
- 101
- OPM %
- 13
- Other Income
- 15
- Interest
- 1
- Depreciation
- 17
- 83
- Tax %
- 26
- Net Profit
- 62
- EPS
- 25
- Dividend Payout %
- 41
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 25
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 25
Mar 2023
- 1,003
- 838
- Operating Profit
- 191
- OPM %
- 19
- Other Income
- 26
- Interest
- 1
- Depreciation
- 16
- 134
- Tax %
- 26
- Net Profit
- 99
- EPS
- 40
- Dividend Payout %
- 40
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 40
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 40
Mar 2024
- 1,296
- 1,111
- Operating Profit
- 219
- OPM %
- 17
- Other Income
- 35
- Interest
- 1
- Depreciation
- 15
- 220
- Tax %
- 26
- Net Profit
- 162
- EPS
- 65
- Dividend Payout %
- 37
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 65
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 65
Mar 2025
- 1,716
- 1,462
- Operating Profit
- 295
- OPM %
- 17
- Other Income
- 41
- Interest
- 1
- Depreciation
- 40
- 156
- Tax %
- 26
- Net Profit
- 116
- EPS
- 46
- Dividend Payout %
- 69
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 46
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 46
Mar 2026
- 2,276
- 2,014
- Operating Profit
- 291
- OPM %
- 13
- Other Income
- 28
- Interest
- 4
- Depreciation
- 29
- 252
- Tax %
- 26
- Net Profit
- 188
- EPS
- 75
- Dividend Payout %
- 48
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 75
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 75
TTM
- 2,432
- 2,209
- Operating Profit
- —
- OPM %
- —
- Other Income
- 26
- Interest
- 6
- Depreciation
- 17
- 228
- Tax %
- 26
- Net Profit
- 170
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 15%
- 5 Years:
- 23%
- 3 Years:
- 31%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 43%
- 5 Years:
- 15%
- 3 Years:
- 24%
STOCK PRICE CAGR
- 10 Years:
- 21%
- 5 Years:
- 19%
- 3 Years:
- 21%
- 1 Year:
- -12%
RETURN ON EQUITY
- 10 Years:
- 18%
- 5 Years:
- 19%
- 3 Years:
- 21%
- Last Year:
- 23%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| 216 | 240 | 294 | 358 | 450 | 504 | 581 | 704 | 758 | 861 | |
| Trade Payables | 88 | 127 | 168 | 210 | 178 | 190 | 228 | 197 | 456 | 783 |
| 205 | 203 | 124 | 203 | 241 | 277 | 328 | 372 | 618 | 728 | |
| Total Liabilities | 514 | 575 | 591 | 776 | 874 | 977 | 1,142 | 1,277 | 1,838 | 2,377 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 87 | 75 | 75 | 72 | 81 | 74 | 69 | 67 | 64 | 117 | |
| Capital Work in Progress | 5 | 4 | 7 | 24 | 4 | 2 | 1 | 0 | 0 | 0 |
| 58 | 113 | 118 | 165 | 160 | 140 | 190 | 228 | 548 | 1,027 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 153 | 185 | 214 | |
| Cash & Bank | 116 | 126 | 173 | 253 | 352 | 448 | 500 | 506 | 537 | 449 |
| 249 | 257 | 218 | 262 | 277 | 312 | 381 | 323 | 503 | 570 | |
| Total Assets | 514 | 575 | 591 | 776 | 874 | 977 | 1,142 | 1,277 | 1,838 | 2,377 |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Working Capital | 61 | 114 | 146 | 215 | 315 | 373 | 452 | 576 | 639 | 750 |
| Contingent Liabilities | 16 | 7 | 27 | 67 | 86 | 123 | 132 | 138 | 98 | 121 |
| Book Value per Share | 88.49 | 97.94 | 119.48 | 145.14 | 181.83 | 203.78 | 234.45 | 283.45 | 305.28 | 346.51 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Working Capital | 61 | 114 | 146 | 215 | 315 | 373 | 452 | 576 | 639 | 750 |
| Contingent Liabilities | 16 | 7 | 27 | 67 | 86 | 123 | 132 | 138 | 98 | 121 |
| Book Value per Share | 88.49 | 97.94 | 119.48 | 145.14 | 181.83 | 203.78 | 234.45 | 283.45 | 305.28 | 346.51 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Mar 2017
- Equity Capital
- 5
- 216
- Trade Payables
- 88
- 205
- Total Liabilities
- 514
- 87
- Capital Work in Progress
- 5
- 58
- 0
- Cash & Bank
- 116
- 249
- Total Assets
- 514
- Total Debt
- 0
- Net Working Capital
- 61
- Contingent Liabilities
- 16
- Book Value per Share
- 88.49
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 61
- Contingent Liabilities
- 16
- Book Value per Share
- 88.49
- Face Value
- 2.00
Mar 2018
- Equity Capital
- 5
- 240
- Trade Payables
- 127
- 203
- Total Liabilities
- 575
- 75
- Capital Work in Progress
- 4
- 113
- 0
- Cash & Bank
- 126
- 257
- Total Assets
- 575
- Total Debt
- 0
- Net Working Capital
- 114
- Contingent Liabilities
- 7
- Book Value per Share
- 97.94
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 114
- Contingent Liabilities
- 7
- Book Value per Share
- 97.94
- Face Value
- 2.00
Mar 2019
- Equity Capital
- 5
- 294
- Trade Payables
- 168
- 124
- Total Liabilities
- 591
- 75
- Capital Work in Progress
- 7
- 118
- 0
- Cash & Bank
- 173
- 218
- Total Assets
- 591
- Total Debt
- 0
- Net Working Capital
- 146
- Contingent Liabilities
- 27
- Book Value per Share
- 119.48
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 146
- Contingent Liabilities
- 27
- Book Value per Share
- 119.48
- Face Value
- 2.00
Mar 2020
- Equity Capital
- 5
- 358
- Trade Payables
- 210
- 203
- Total Liabilities
- 776
- 72
- Capital Work in Progress
- 24
- 165
- 0
- Cash & Bank
- 253
- 262
- Total Assets
- 776
- Total Debt
- 0
- Net Working Capital
- 215
- Contingent Liabilities
- 67
- Book Value per Share
- 145.14
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 215
- Contingent Liabilities
- 67
- Book Value per Share
- 145.14
- Face Value
- 2.00
Mar 2021
- Equity Capital
- 5
- 450
- Trade Payables
- 178
- 241
- Total Liabilities
- 874
- 81
- Capital Work in Progress
- 4
- 160
- 0
- Cash & Bank
- 352
- 277
- Total Assets
- 874
- Total Debt
- 0
- Net Working Capital
- 315
- Contingent Liabilities
- 86
- Book Value per Share
- 181.83
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 315
- Contingent Liabilities
- 86
- Book Value per Share
- 181.83
- Face Value
- 2.00
Mar 2022
- Equity Capital
- 5
- 504
- Trade Payables
- 190
- 277
- Total Liabilities
- 977
- 74
- Capital Work in Progress
- 2
- 140
- 0
- Cash & Bank
- 448
- 312
- Total Assets
- 977
- Total Debt
- 0
- Net Working Capital
- 373
- Contingent Liabilities
- 123
- Book Value per Share
- 203.78
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 373
- Contingent Liabilities
- 123
- Book Value per Share
- 203.78
- Face Value
- 2.00
Mar 2023
- Equity Capital
- 5
- 581
- Trade Payables
- 228
- 328
- Total Liabilities
- 1,142
- 69
- Capital Work in Progress
- 1
- 190
- 0
- Cash & Bank
- 500
- 381
- Total Assets
- 1,142
- Total Debt
- 0
- Net Working Capital
- 452
- Contingent Liabilities
- 132
- Book Value per Share
- 234.45
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 452
- Contingent Liabilities
- 132
- Book Value per Share
- 234.45
- Face Value
- 2.00
Mar 2024
- Equity Capital
- 5
- 704
- Trade Payables
- 197
- 372
- Total Liabilities
- 1,277
- 67
- Capital Work in Progress
- 0
- 228
- 153
- Cash & Bank
- 506
- 323
- Total Assets
- 1,277
- Total Debt
- 0
- Net Working Capital
- 576
- Contingent Liabilities
- 138
- Book Value per Share
- 283.45
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 576
- Contingent Liabilities
- 138
- Book Value per Share
- 283.45
- Face Value
- 2.00
Mar 2025
- Equity Capital
- 5
- 758
- Trade Payables
- 456
- 618
- Total Liabilities
- 1,838
- 64
- Capital Work in Progress
- 0
- 548
- 185
- Cash & Bank
- 537
- 503
- Total Assets
- 1,838
- Total Debt
- 0
- Net Working Capital
- 639
- Contingent Liabilities
- 98
- Book Value per Share
- 305.28
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 639
- Contingent Liabilities
- 98
- Book Value per Share
- 305.28
- Face Value
- 2.00
Mar 2026
- Equity Capital
- 5
- 861
- Trade Payables
- 783
- 728
- Total Liabilities
- 2,377
- 117
- Capital Work in Progress
- 0
- 1,027
- 214
- Cash & Bank
- 449
- 570
- Total Assets
- 2,377
- Total Debt
- 0
- Net Working Capital
- 750
- Contingent Liabilities
- 121
- Book Value per Share
- 346.51
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 750
- Contingent Liabilities
- 121
- Book Value per Share
- 346.51
- Face Value
- 2.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 38 | 9 | 55 | 87 | 105 | 101 | 58 | 28 | 65 | -15 | |
| Cash from Investing | 0 | -9 | 4 | -171 | 173 | 5 | 18 | 22 | 31 | 19 |
| Cash from Financing | 0 | 0 | 0 | -6 | -9 | -9 | -24 | -44 | -66 | -92 |
| 38 | -1 | 59 | -90 | 269 | 96 | 52 | 5 | 31 | -88 | |
| Free Cash Flow | 38 | 7 | 38 | 57 | 98 | 94 | 49 | 21 | 35 | -15 |
| OCF / Net Profit | 1.90 | 0.34 | 1.01 | 1.21 | 1.12 | 1.64 | 0.59 | 0.17 | 0.56 | -0.08 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 238 | 293 | 335 | 318 | 297 | 183 |
| OCF / Net Profit | 1.90 | 0.34 | 1.01 | 1.21 | 1.12 | 1.64 | 0.59 | 0.17 | 0.56 | -0.08 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 238 | 293 | 335 | 318 | 297 | 183 |
Mar 2017
- 38
- Cash from Investing
- 0
- Cash from Financing
- 0
- 38
- Free Cash Flow
- 38
- OCF / Net Profit
- 1.90
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.90
- Cumulative 5-Year FCF
- 0
Mar 2018
- 9
- Cash from Investing
- -9
- Cash from Financing
- 0
- -1
- Free Cash Flow
- 7
- OCF / Net Profit
- 0.34
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.34
- Cumulative 5-Year FCF
- 0
Mar 2019
- 55
- Cash from Investing
- 4
- Cash from Financing
- 0
- 59
- Free Cash Flow
- 38
- OCF / Net Profit
- 1.01
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.01
- Cumulative 5-Year FCF
- 0
Mar 2020
- 87
- Cash from Investing
- -171
- Cash from Financing
- -6
- -90
- Free Cash Flow
- 57
- OCF / Net Profit
- 1.21
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.21
- Cumulative 5-Year FCF
- 0
Mar 2021
- 105
- Cash from Investing
- 173
- Cash from Financing
- -9
- 269
- Free Cash Flow
- 98
- OCF / Net Profit
- 1.12
- Cumulative 5-Year FCF
- 238
- OCF / Net Profit
- 1.12
- Cumulative 5-Year FCF
- 238
Mar 2022
- 101
- Cash from Investing
- 5
- Cash from Financing
- -9
- 96
- Free Cash Flow
- 94
- OCF / Net Profit
- 1.64
- Cumulative 5-Year FCF
- 293
- OCF / Net Profit
- 1.64
- Cumulative 5-Year FCF
- 293
Mar 2023
- 58
- Cash from Investing
- 18
- Cash from Financing
- -24
- 52
- Free Cash Flow
- 49
- OCF / Net Profit
- 0.59
- Cumulative 5-Year FCF
- 335
- OCF / Net Profit
- 0.59
- Cumulative 5-Year FCF
- 335
Mar 2024
- 28
- Cash from Investing
- 22
- Cash from Financing
- -44
- 5
- Free Cash Flow
- 21
- OCF / Net Profit
- 0.17
- Cumulative 5-Year FCF
- 318
- OCF / Net Profit
- 0.17
- Cumulative 5-Year FCF
- 318
Mar 2025
- 65
- Cash from Investing
- 31
- Cash from Financing
- -66
- 31
- Free Cash Flow
- 35
- OCF / Net Profit
- 0.56
- Cumulative 5-Year FCF
- 297
- OCF / Net Profit
- 0.56
- Cumulative 5-Year FCF
- 297
Mar 2026
- -15
- Cash from Investing
- 19
- Cash from Financing
- -92
- -88
- Free Cash Flow
- -15
- OCF / Net Profit
- -0.08
- Cumulative 5-Year FCF
- 183
- OCF / Net Profit
- -0.08
- Cumulative 5-Year FCF
- 183
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 8.02 | 10.36 | 21.78 | 28.88 | 37.32 | 24.64 | 39.72 | 64.60 | 46.30 | 75.01 |
| Book Value (₹) | 88.49 | 97.94 | 119.48 | 145.14 | 181.83 | 203.78 | 234.45 | 283.45 | 305.28 | 346.51 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 1.00 | 2.00 | 10.00 | 16.00 | 24.00 | 32.00 | 36.00 |
| Cash EPS (₹) | 14.35 | 16.26 | 27.75 | 36.32 | 45.37 | 31.42 | 46.22 | 70.58 | 62.29 | 86.44 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 9.36% | 10.23% | 11.97% | 16.01% | 18.15% | 12.47% | 18.98% | 14.17% | 14.74% | 11.48% |
| Net Margin % | 3.65% | 4.53% | 7.44% | 8.65% | 11.42% | 7.61% | 9.85% | 12.40% | 6.72% | 8.22% |
| ROE % | 10.63% | 11.12% | 20.03% | 21.83% | 22.83% | 12.78% | 18.13% | 24.95% | 15.73% | 23.02% |
| ROCE % | 18.74% | 18.65% | 26.53% | 34.61% | 31.24% | 17.36% | 24.49% | 33.94% | 21.29% | 31.24% |
| 4.25% | 4.76% | 9.34% | 10.57% | 11.31% | 6.65% | 9.37% | 13.35% | 7.43% | 8.90% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 42 | 31 | 34 | 36 | 38 | 39 | 35 | 37 | 36 | 32 |
| Inventory Days | 45 | 55 | 58 | 62 | 73 | 68 | 60 | 59 | 82 | 126 |
| Payable Days | 194 | 220 | 238 | 230 | 247 | 220 | 215 | 131 | 124 | 164 |
| -108 | -134 | -147 | -132 | -136 | -114 | -120 | -36 | -6 | -6 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Interest Coverage (x) | 0.00x | 0.00x | 0.00x | 100.97x | 117.60x | 88.41x | 213.86x | 183.95x | 108.10x | 57.17x |
| 1.30x | 1.52x | 1.54x | 1.59x | 1.84x | 1.95x | 1.93x | 2.23x | 1.70x | 1.68x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -3.55% | 5.02% | 27.55% | 14.21% | -2.19% | -0.98% | 24.50% | 29.17% | 32.48% | 32.59% |
| Operating Profit Growth % | 121.35% | 14.05% | 49.62% | 52.63% | 10.94% | -31.94% | 89.44% | 14.66% | 34.37% | -1.38% |
| Net Profit Growth % | 281.25% | 29.23% | 110.15% | 32.62% | 29.21% | -33.98% | 61.19% | 62.66% | -28.34% | 62.02% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 62.66% | -28.34% | 62.02% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 82.35x | 185.90x | 103.45x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 18.77x | 28.19x | 22.39x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.45% | 0.37% | 0.46% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 58.36x | 71.21x | 65.23x |
Mar 2017
- EPS (₹)
- 8.02
- Book Value (₹)
- 88.49
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 14.35
- Operating Margin %
- 9.36%
- Net Margin %
- 3.65%
- ROE %
- 10.63%
- ROCE %
- 18.74%
- 4.25%
- Debtor Days
- 42
- Inventory Days
- 45
- Payable Days
- 194
- -108
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 0.00x
- 1.30x
- Revenue Growth %
- -3.55%
- Operating Profit Growth %
- 121.35%
- Net Profit Growth %
- 281.25%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 10.36
- Book Value (₹)
- 97.94
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 16.26
- Operating Margin %
- 10.23%
- Net Margin %
- 4.53%
- ROE %
- 11.12%
- ROCE %
- 18.65%
- 4.76%
- Debtor Days
- 31
- Inventory Days
- 55
- Payable Days
- 220
- -134
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 0.00x
- 1.52x
- Revenue Growth %
- 5.02%
- Operating Profit Growth %
- 14.05%
- Net Profit Growth %
- 29.23%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 21.78
- Book Value (₹)
- 119.48
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 27.75
- Operating Margin %
- 11.97%
- Net Margin %
- 7.44%
- ROE %
- 20.03%
- ROCE %
- 26.53%
- 9.34%
- Debtor Days
- 34
- Inventory Days
- 58
- Payable Days
- 238
- -147
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 0.00x
- 1.54x
- Revenue Growth %
- 27.55%
- Operating Profit Growth %
- 49.62%
- Net Profit Growth %
- 110.15%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 28.88
- Book Value (₹)
- 145.14
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 36.32
- Operating Margin %
- 16.01%
- Net Margin %
- 8.65%
- ROE %
- 21.83%
- ROCE %
- 34.61%
- 10.57%
- Debtor Days
- 36
- Inventory Days
- 62
- Payable Days
- 230
- -132
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 100.97x
- 1.59x
- Revenue Growth %
- 14.21%
- Operating Profit Growth %
- 52.63%
- Net Profit Growth %
- 32.62%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 37.32
- Book Value (₹)
- 181.83
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 45.37
- Operating Margin %
- 18.15%
- Net Margin %
- 11.42%
- ROE %
- 22.83%
- ROCE %
- 31.24%
- 11.31%
- Debtor Days
- 38
- Inventory Days
- 73
- Payable Days
- 247
- -136
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 117.60x
- 1.84x
- Revenue Growth %
- -2.19%
- Operating Profit Growth %
- 10.94%
- Net Profit Growth %
- 29.21%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 24.64
- Book Value (₹)
- 203.78
- Dividend per Share (₹)
- 10.00
- Cash EPS (₹)
- 31.42
- Operating Margin %
- 12.47%
- Net Margin %
- 7.61%
- ROE %
- 12.78%
- ROCE %
- 17.36%
- 6.65%
- Debtor Days
- 39
- Inventory Days
- 68
- Payable Days
- 220
- -114
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 88.41x
- 1.95x
- Revenue Growth %
- -0.98%
- Operating Profit Growth %
- -31.94%
- Net Profit Growth %
- -33.98%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 39.72
- Book Value (₹)
- 234.45
- Dividend per Share (₹)
- 16.00
- Cash EPS (₹)
- 46.22
- Operating Margin %
- 18.98%
- Net Margin %
- 9.85%
- ROE %
- 18.13%
- ROCE %
- 24.49%
- 9.37%
- Debtor Days
- 35
- Inventory Days
- 60
- Payable Days
- 215
- -120
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 213.86x
- 1.93x
- Revenue Growth %
- 24.50%
- Operating Profit Growth %
- 89.44%
- Net Profit Growth %
- 61.19%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 64.60
- Book Value (₹)
- 283.45
- Dividend per Share (₹)
- 24.00
- Cash EPS (₹)
- 70.58
- Operating Margin %
- 14.17%
- Net Margin %
- 12.40%
- ROE %
- 24.95%
- ROCE %
- 33.94%
- 13.35%
- Debtor Days
- 37
- Inventory Days
- 59
- Payable Days
- 131
- -36
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 183.95x
- 2.23x
- Revenue Growth %
- 29.17%
- Operating Profit Growth %
- 14.66%
- Net Profit Growth %
- 62.66%
- 62.66%
- P/E (x)
- 82.35x
- P/B (x)
- 18.77x
- Dividend Yield %
- 0.45%
- 58.36x
Mar 2025
- EPS (₹)
- 46.30
- Book Value (₹)
- 305.28
- Dividend per Share (₹)
- 32.00
- Cash EPS (₹)
- 62.29
- Operating Margin %
- 14.74%
- Net Margin %
- 6.72%
- ROE %
- 15.73%
- ROCE %
- 21.29%
- 7.43%
- Debtor Days
- 36
- Inventory Days
- 82
- Payable Days
- 124
- -6
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 108.10x
- 1.70x
- Revenue Growth %
- 32.48%
- Operating Profit Growth %
- 34.37%
- Net Profit Growth %
- -28.34%
- -28.34%
- P/E (x)
- 185.90x
- P/B (x)
- 28.19x
- Dividend Yield %
- 0.37%
- 71.21x
Mar 2026
- EPS (₹)
- 75.01
- Book Value (₹)
- 346.51
- Dividend per Share (₹)
- 36.00
- Cash EPS (₹)
- 86.44
- Operating Margin %
- 11.48%
- Net Margin %
- 8.22%
- ROE %
- 23.02%
- ROCE %
- 31.24%
- 8.90%
- Debtor Days
- 32
- Inventory Days
- 126
- Payable Days
- 164
- -6
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 57.17x
- 1.68x
- Revenue Growth %
- 32.59%
- Operating Profit Growth %
- -1.38%
- Net Profit Growth %
- 62.02%
- 62.02%
- P/E (x)
- 103.45x
- P/B (x)
- 22.39x
- Dividend Yield %
- 0.46%
- 65.23x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-21 - AstraZeneca Pharma India Limited has informed the Exchange about Schedule of meet
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-15 - AstraZeneca Pharma India Limited has informed the Exchange about Schedule of meet
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2025
Aug 2024
Aug 2023